Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
Patents for C07D 317 - Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms (18,224)
12/2003
12/02/2003US6656943 1-phenyl-4-benzlpiperazines: dopamine receptor subtype specific ligands
12/02/2003CA2244785C Pentafluorobenzenesulfonamides and analogs
11/2003
11/27/2003WO2003097586A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/27/2003WO2003097576A2 Diamino-functional chalcones
11/27/2003WO2003097575A2 Amino-functional chalcones
11/27/2003WO2003097574A2 Aminoalkoxy-functional chalcones
11/27/2003WO2003097568A1 Process for producing 4-phenyl-4-oxo-2-butenoic ester derivative
11/27/2003WO2003014064A8 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists
11/27/2003WO2003009850A1 Substituted piperazines as modulators of the melanocortin receptor
11/27/2003WO2002100813A3 Modulators of peroxisome proliferator activated receptors
11/27/2003US20030220399 Use of (-) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of insulin resistance, Type 2 diabetes, hyperlipidemia and hyperuricemia
11/27/2003US20030220392 Prophylaxis of bacterial infections by administering 2'-(6-Chloropiperonyl)-3-(2,6-dichlorobenzyloxy)cinnamic acid and/or racemic mixtures, as antibiotics
11/27/2003US20030220388 Indoline derivatives
11/27/2003US20030220350 For example, 3-(4-((N-(5-chlorobenzo(B)thiophen-3-carbonyl)-N-(2,2-diphenyl ethyl)amino)methyl)benzoylamino)propionic acid; for treatment or prevention of glucagon-mediated diseases such as diabetes
11/27/2003US20030220324 Substituted piperazines and methods of use
11/27/2003CA2486092A1 Aminotetralin-derived urea modulators of vanilloid vr1 receptor
11/26/2003EP1363876A1 Glucocorticoid receptor modulators
11/26/2003EP1363873A2 Peptide deformylase inhibitors
11/26/2003EP0930311B1 Process for preparing 1,3-dioxolane-4-methanol compounds
11/26/2003CN1458153A Process for extracting piperine
11/26/2003CN1128796C Process for production of 1,3-dioxolane
11/25/2003US6653483 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist-like biological activity
11/25/2003US6653344 Pharmaceutical preparations containing a dibenzocyclooctane lignan derivative for treatment of neurodegenerative disease
11/25/2003US6653309 Binding ligands
11/25/2003US6653258 Pyridinyl-substituted- methyl 3-methoxy-2-phenylacrylate derivatives; agricultural miticides and nematocides
11/25/2003US6652905 Piezoelectric element and process for production thereof
11/24/2003CA2387644A1 1,3-oxazolium-5-oxides or their alpha-amidoketene tautomers, process of preparation and uses thereof
11/20/2003WO2003095443A1 Alkylene carbonate purification method
11/20/2003WO2003095437A1 Aralkyl formyl-alkyl piperazine derivatives and their uses as cerebral nerve protective agent
11/20/2003WO2003094918A1 Substituted piperazine as melanocortin receptors ligands
11/20/2003WO2001085664A8 Compounds and methods for regulating bacterial growth and pathogenesis
11/20/2003US20030216435 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
11/20/2003US20030216405 Hydroxycarbonyl or alkyloxycarbonyl or aminohydroxycarbonyl substituted sulfonamide compounds useful as procollagen C-protenase inhibitor
11/20/2003US20030216403 An aromatic alkylamino compound containing a lipophilic group useful as antithrombotic agent as well as treats asthma
11/20/2003US20030216397 A compound having a fused ecteinascidin five ring system with a 1,4 bridge; anticarcinogenic agent
11/20/2003US20030215478 For floral/jasmine fragrances/flavorings
11/20/2003CA2484968A1 Substituted piperazine as melanocortin receptors ligands
11/19/2003EP1362844A1 Benzylamine analogue
11/19/2003EP1362039A1 Heterocyclic substituted carbonyl derivatives and their use as dopamine d3 receptor ligands
11/19/2003EP1362028A2 Isophthalic acid derivatives as matrix metalloproteinase inhibitors
11/19/2003EP1361873A2 Matrix metalloproteinase inhibitors
11/19/2003EP0973392B1 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds
11/19/2003EP0945452B1 Sugar compounds, gelling agents, gelling agent compositions, processes for the preparation of them, and gel compositions
11/19/2003CN1128145C Process for preparing piperine
11/18/2003US6649657 Prevention of loss and restoration of bone mass by certain prostaglandin agonists
11/18/2003US6649612 Biphenyl derivatives substituted with an aromatic or heteroaromatic radical, and pharmaceutical and cosmetic compositions containing them
11/18/2003US6649587 Polyamine analog conjugates and quinone conjugates as therapies for cancers and prostate diseases
11/13/2003WO2003093223A1 Biphenyl carboxamides
11/13/2003WO2003024448A3 Inhibitors of histone deacetylase
11/13/2003WO2002098849A3 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer’s disease and similar diseases
11/13/2003WO2001040188A8 Curcumin analogues for treating cancer
11/13/2003US20030212280 Alkylene carbonate purification
11/13/2003US20030212140 Analgesics; central nervous system disorders
11/12/2003EP1361210A2 Novel immunotherapeutic agents and their use in the reduction of cytokine levels
11/12/2003EP1206444B1 Compounds that inhibit tryptase activity
11/12/2003CN1455776A Process for producing cyclic formal
11/12/2003CN1127496C Method for producing monohalogenated 2-oxo-1,3-dioxolanes
11/12/2003CN1127479C Sulfonyl urea derivatives ad their use in control of interleukin-1 activity
11/12/2003CN1127470C Novel tetralone or benzopyranone derivatives and process for producing same
11/11/2003US6646243 Fixing biopolymers to substrate; obtain substrate, incubate with nucleotide sequences, expose to activator, recover product
11/11/2003US6646137 Non-peptide GnRH agents
11/11/2003US6646012 Central nervous system analgesic; hypotensive agents; antiarrhythmia agents; antidiabetic agents
11/11/2003US6646010 α- and β-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
11/11/2003US6645992 Malonamid and malonamic ester derivatives with antithrombotic activity, their preparation, and their use
11/06/2003WO2003091189A1 Cannabinoids
11/06/2003WO2003066889A3 Assay for acytyltransferase or deacetylase activity
11/06/2003WO2003050092A3 Process for the preparation of tofisopam and new intermediates
11/06/2003WO2003039539A3 Use of endothelin receptor antagonists in the treatment of tumour diseases
11/06/2003WO2002094799A3 Melanin concentrating hormone receptor ligands: substituted 1-benzyl-4-aryl piperazine analogues
11/06/2003US20030208081 Carbocyclic ethers such as (Methyl-(3-(4-phenoxy-phenoxy)-3-phenyl-propyl)-amino)-acetic acid, used as neurotransmitter antagonists, for prophylaxis of psychological disorders
11/06/2003US20030207939 Novel 3-substituted urea derivatives and medicinal use thereof
11/06/2003US20030207919 For treating, preventing, reducing inflammation, pain, fever,gastrointestinal disorders; decreasing gastrointestinal, renal and other toxicities resulting from use of nonsteroidal antiinflammatory drugs; multiplicity of compounds
11/06/2003US20030207898 Sulfides such as N-(2-(((6- chloro-1,3-benzodioxol-5-yl)methyl )thio)phenyl)thiophene-2-carboxamide used for controlling metabolism of lipids and prophylaxis of diabetes, Alzheimers disease, atherosclerosis, dyslipidemia and genetic disorders
11/06/2003US20030207894 1,4-Disubstituted benzenes as insecticides
11/06/2003US20030207861 Novel compounds as NS3-serine protease inhibitors of hepatitis C virus
11/06/2003US20030207812 Cd45 inhibitors
11/06/2003US20030207469 Via immunoassay; low cross-reactivity with ephedrine and other compounds; antibody produced by a methylene dioxyphenyl derivative of agiven structure
11/06/2003CA2483072A1 Cannabinoids
11/05/2003EP1358171A2 Novel urea derivatives, method for preparing same, use thereof as medicines, pharmaceutical compositions and novel use
11/05/2003EP1358144A1 Epothilone synthesis components iii and iv: asymmetrically substituted acyloins and acyloin derivatives, method for the production thereof and method for the production of epithilone b, d and epothilone derivatives
11/05/2003EP1066246B1 Novel cationic couplers and their use for oxidation dyeing
11/05/2003CN1454086A High affinity small molecule C5A receptor modulators
11/04/2003US6642424 Diels-Alder process; antitumor agents
11/04/2003US6642270 7-substituted fused ring tetracycline compounds
11/04/2003US6642251 Antitumor, 2-indolinone derivatives
10/2003
10/30/2003WO2003088927A2 Novel curcumin analogues and uses thereof
10/30/2003WO2003066579A3 Novel bicyclic hydroxamates as inhibitors of histone deacetylase
10/30/2003WO2002102765A3 Protected tyrosine derivatives, method for the production thereof and use of the same for producing o-(2-[18f]-fluoroethyl)-l-tyrosine
10/30/2003US20030204099 Process for producing a fluorine-containing compound by liquid phase fluorination
10/30/2003US20030204085 3, 4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor antagonists
10/30/2003US20030203965 Benzyl (S,S)-2-(2-acetylsulphanylmethyl-3-benzo(1,3)dioxol-5-ylpropionyl -amino)propionate; differential scanning calorimetry; for treatment of hypertension/cardiovascular system disorders
10/30/2003US20030203941 Substituted phenyl compounds for the treatment of non-insulin dependent diabetes mellitus
10/30/2003US20030203933 Novel curcumin analogues and uses thereof
10/30/2003US20030203915 Compounds that are nitrosated and/or nitrosylated through one or more sites such as oxygen (hydroxyl condensation), sulfur (sulfhydryl condensation) and/or nitrogen
10/29/2003EP1357118A1 Process for preparation of esculetin compounds, esculetin compounds and intermediates thereof, and use of both
10/29/2003EP1355875A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc chemokine receptor antagonists
10/29/2003EP1355619A1 Colouring agents for keratin fibres containing (1.1'-biphenyl)-2.4-diamine derivatives in addition to novel (1.1'-biphenyl)-2.4-diamine-derivatives
10/29/2003CN1452617A Acid-sensitive compounds, preparation and uses thereof
10/28/2003US6639105 For inhibiting tumor cell growth
10/28/2003US6639087 Reacting a nucleophile and a chiral or prochiral cyclic substrate in the presence of a chiral, nonracemic catalyst; changing the oxidation state of catalyst residue to prevent degradation of product mixture; stereospecific
1 ... 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 ... 183